Precision Antibody is a global leader in custom antibody development services. We have a track record of delivering successful projects to our customers in record time. We provide comprehensive services covering all applications from research tools, diagnostic to therapeutic antibody development.
Precision Antibody is always here to help you with your antibody needs.
Call us directly at 410-884-4100 or complete the form below and we will contact you by phone or e-mail within the next business day.
Along with custom antibodies, Precision Antibody continuously develops a boutique catalog of optimized research antibodies to biomarkers in oncology and infectious disease. Take a look at our ready-to-ship purified monoclonal and polyclonal antibodies which include our new selection of Covid-19 antibodies.
Precision Antibody offers fully human antibody development using transgenic mice. We are capable of developing a large number of antigen-specific clones producing fully human IgG in about 60 days. Precision Antibody uses their proprietary procedures and platform to rapidly generate application specific monoclonal antibodies (mAbs). Please inquire.
Precision Antibody has extensive experience developing anti-idiotypic antibodies (anti-idiotype) for pharmacokinetic (PK) and pharmacodynamic studies. Our team of immunologists has developed a successful immunization protocol that has vastly improved the generation of anti-idiotypic antibodies. We have developed anti-idiotypes for large and small biotechnology and pharmaceutical customers.
Precision Antibody has become a household name for customized mAb development. Our team of scientists will develop a strategy to match the needs of your diagnostic or therapeutic program, including modifying the scale and scope of the program to identify mAbs for drug development.
Rapid monoclonal antibody development to generate Monoclonal Antibodies for basic research in immunoassays. Precision Antibody can target proteins, peptides, small molecules and other antigens to make mAbs as antibody tools. mAbs are identified for binding utility and can be characterized for Ab production and binding affinity.
Celebrating over 20 years in business, Precision Antibody has found itself in the forefront of the global Custom Antibody industry. Led by the innovative minds in immunology and antibody development field, Precision Antibody not only has implemented a cutting-edge technique in antigen design, antibody development, production, and other analyses, but is also constantly working on ways to improve and advance technology to match the ever-changing world of science.
Columbia, Maryland – Dr. Ginette Serrero, CEO of A&G Pharmaceutical Inc., DBA Precision Antibody, will present two posters at the American Association of Cancer Research’s (AACR) Annual Meeting in Orlando, Florida, April 14-19, 2023. The
Precision Antibody has an exclusive license agreement with trans-chromosomic (Tc) mice carrying mini-chromosomes with megabase-sized human immunoglobulin (Ig) loci. Precision Antibody has developed a proprietary method to develop a strong immune response against therapeutic targets
Precision Antibody contributes to the development of novel antibody reagents for the RAS signaling network The National Cancer Institute (NCI)’s RAS initiative has been working with the Office of Cancer Clinical Proteomics Research (OCCPR) to
We pride ourselves on our customer service!
